Powell, AA;
Ireland, G;
Leeson, R;
Lacey, A;
Ford, B;
Poh, J;
Ijaz, S;
Shute, J;
Cherepanov, P;
Tedder, R;
et al.
Powell, AA; Ireland, G; Leeson, R; Lacey, A; Ford, B; Poh, J; Ijaz, S; Shute, J; Cherepanov, P; Tedder, R; Bottomley, C; Dawe, F; Mangtani, P; Jones, P; Nguipdop-Djomo, P; Ladhani, SN; COVID-19 Schools Infection Survey Group
(2023)
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.
J Infect, 86 (4).
pp. 361-368.
ISSN 1532-2742
https://doi.org/10.1016/j.jinf.2023.02.016
SGUL Authors: Ladhani, Shamez Nizarali
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (969kB) | Preview |
|
![]() |
Microsoft Word (.docx) (Supplementary material)
Published Version
Available under License Creative Commons Attribution. Download (161kB) |
Abstract
BACKGROUND: SARS-CoV-2 infection rates are likely to be underestimated in children because of asymptomatic or mild infections. We aim to estimate national and regional prevalence of SARS-CoV-2 antibodies in primary (4-11 years old) and secondary (11-18 years old) school children between 10 November and 10 December 2021. METHODS: Cross-sectional surveillance in England using two-stage sampling, firstly stratifying into regions and selecting local authorities, then selecting schools according to a stratified sample within selected local authorities. Participants were sampled using a novel oral fluid-validated assay for SARS-CoV-2 spike and nucleocapsid IgG antibodies. RESULTS: 4980 students from 117 state-funded schools (2706 from 83 primary schools, 2274 from 34 secondary schools) provided a valid sample. After weighting for age, sex, and ethnicity, and adjusting for assay accuracy, the national prevalence of SARS-CoV-2 antibodies in primary school students, who were all unvaccinated, was 40.1% (95% CI 37.3-43.0). Antibody prevalence increased with age (p < 0.001) and was higher in urban than rural schools (p = 0.01). In secondary school students, the adjusted, weighted national prevalence of SARS-CoV-2 antibodies was 82.4% (95% CI 79.5-85.1); including 71.5% (95% CI 65.7-76.8) in unvaccinated and 97.5% (95% CI 96.1-98.5) in vaccinated students. Antibody prevalence increased with age (p < 0.001), and was not significantly different in urban versus rural students (p = 0.1). CONCLUSIONS: In November 2021, using a validated oral fluid assay, national SARS-CoV-2 seroprevalence was estimated to be 40.1% in primary school students and 82.4% in secondary school students. In unvaccinated children, this was approximately threefold higher than confirmed infections highlighting the importance of seroprevalence studies to estimate prior exposure. DATA AVAILABILITY: Deidentified study data are available for access by accredited researchers in the ONS Secure Research Service (SRS) for accredited research purposes under part 5, chapter 5 of the Digital Economy Act 2017. For further information about accreditation, contact Research.support@ons.gov.uk or visit the SRS website.
Statistics
Actions (login required)
![]() |
Edit Item |